Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report)’s stock price traded down 3.6% during mid-day trading on Tuesday . The company traded as low as $47.83 and last traded at $47.83. 500 shares changed hands during trading, a decline of 9% from the average session volume of 550 shares. The stock had previously closed at $49.60.
Shionogi & Co., Ltd. Stock Performance
The stock has a 50 day simple moving average of $50.80 and a 200-day simple moving average of $47.81.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
Further Reading
- Five stocks we like better than Shionogi & Co., Ltd.
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Garmin Navigates to New Highs Driven By Wearables Trend
- Stock Market Upgrades: What Are They?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Calculate Stock Profit
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
